SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-007673
Filing Date
2020-01-15
Accepted
2020-01-15 10:03:13
Documents
16
Period of Report
2020-01-15
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d801894d8k.htm   iXBRL 8-K 51223
2 EX-3.1 d801894dex31.htm EX-3.1 7607
3 EX-3.2 d801894dex32.htm EX-3.2 53899
4 EX-99.1 d801894dex991.htm EX-99.1 14100
8 GRAPHIC g801894img1.jpg GRAPHIC 21067
  Complete submission text file 0001193125-20-007673.txt   311556

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bold-20200115.xsd EX-101.SCH 3076
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bold-20200115_lab.xml EX-101.LAB 18890
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bold-20200115_pre.xml EX-101.PRE 11864
11 EXTRACTED XBRL INSTANCE DOCUMENT d801894d8k_htm.xml XML 3579
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 20527355
SIC: 2836 Biological Products, (No Diagnostic Substances)